协调戒烟治疗与月经周期时相以改善戒烟结局(MC-NRT):一项随机对照试验的研究方案
该随机对照试验将1200名参与者随机分配至三个目标戒烟日设定组:黄体中期、卵泡中期或入组后15-30天且不考虑月经周期时相(常规做法)。参与者接受6周联合尼古丁替代疗法(NRT)及可选行为支持,通过干血斑可替宁浓度评估目标戒烟日后7天、6周和6个月的吸烟状态。
要点
- 女性戒烟难度高于男性,月经周期激素波动可能影响戒烟成功率。
- 试验将1200人随机分至黄体中期、卵泡中期或常规设定目标戒烟日三组。
- 通过干血斑可替宁浓度在目标戒烟日后7天、6周和6个月评估吸烟状态。
核心结论
- 该试验旨在阐明将目标戒烟日设定在卵泡期或黄体期是否能提高戒烟率,并进一步阐明月经周期对戒烟结局的影响以及将月经周期时相策略与可及、低成本的NRT相结合是否有益。
研究设计与样本
- 随机对照试验,计划随机分配1200名符合条件的个体至三个目标戒烟日设定组:黄体中期、卵泡中期或入组后15-30天且不考虑月经周期时相(常规做法)。
- 参与者加入提供尼古丁替代疗法(NRT)和行为支持的在线戒烟项目,接受6周联合NRT(尼古丁贴片加自选尼古丁口香糖或含片),并被告知在目标戒烟日开始使用NRT。
- 可选行为支持包括免费可下载应用程序和简短视频,通过电子邮件发送,聚焦于制定戒烟计划、应对渴求与预防复吸。
- 通过干血斑可替宁浓度分析在目标戒烟日后7天、6周和6个月评估吸烟状态。
临床怎么用
- 原文未据此给出推荐。
局限性
- 既往证据受限于样本量小和目标戒烟日变异性大。
- 该试验旨在通过招募大样本参与者并将目标戒烟日设定在卵泡中期和黄体中期来克服既往研究的局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Women experience greater difficulty achieving smoking abstinence compared to men. Recent evidence suggests that hormonal fluctuations during different phases of the menstrual cycle can contribute to lower smoking abstinence rates following a quit attempt among women. However, these findings are limited by small sample sizes and variability among targeted smoking quit dates. This clinical trial aims to clarify whether targeting the quit date to the follicular or luteal phase of the menstrual cycle can improve smoking abstinence. METHODS: Participants will enroll in an online smoking cessation program providing nicotine replacement therapy (NRT) and behavioral support. We will randomize 1200 eligible individuals to set a target quit date: (1) during the mid-luteal phase, (2) during the mid-follicular phase, or (3) 15-30 days after enrollment with no regard to the menstrual cycle phase (usual practice). Participants will receive a 6-week supply of combination NRT consisting of a nicotine patch plus their choice of nicotine gum or lozenge. Participants will be instructed to start using NRT on their target quit date. Optional behavioral support will consist of a free downloadable app and brief videos focusing on building a quit plan, coping with cravings, and relapse prevention, delivered via e-mail. Smoking status will be assessed via dried blood spot analysis of cotinine concentration at 7 days, 6 weeks, and 6 months post-target quit date. DISCUSSION: We aim to overcome the limitations of previous studies by recruiting a large sample of participants and assigning target quit dates to the middle of both the follicular and luteal phases. The results of the trial can further elucidate the effects of the menstrual cycle on smoking cessation outcomes and whether it is beneficial to combine menstrual cycle phase timing strategies with accessible and low-cost NRT. TRIAL REGISTRATION: ClinicalTrials.gov NCT05515354. Registered on August 23, 2022.
引用
- Zawertailo L, Kabir T, Voci S, et al. Coordinating smoking cessation treatment with menstrual cycle phase to improve quit outcomes (MC-NRT): study protocol for a randomized controlled trial. Trials. 2023. PMID: 37005655. doi:10.1186/s13063-023-07196-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。